Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study
Objectives: Intrinsic capacity (IC), the composite of all the physical and mental capacities of an individual, has never been studied in patients with dementia with Lewy bodies (DLB). As IC decline is associated with the risk of frailty, functional decline and disability and is potentially reversibl...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | The Journal of Nutrition, Health and Aging |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S127977072500065X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850098486421225472 |
|---|---|
| author | Marie Collin Justine Bonnet-Chateau Victor Gilles Sophie Dautricourt Thomas Gilbert Zaza Makaroff Marie-Hélène Coste Virginie Dauphinot Antoine Garnier-Crussard |
| author_facet | Marie Collin Justine Bonnet-Chateau Victor Gilles Sophie Dautricourt Thomas Gilbert Zaza Makaroff Marie-Hélène Coste Virginie Dauphinot Antoine Garnier-Crussard |
| author_sort | Marie Collin |
| collection | DOAJ |
| description | Objectives: Intrinsic capacity (IC), the composite of all the physical and mental capacities of an individual, has never been studied in patients with dementia with Lewy bodies (DLB). As IC decline is associated with the risk of frailty, functional decline and disability and is potentially reversible after targeted interventions, a monitoring and specific management of IC decline in patients with DLB could promote healthy aging in this population. The aim of this cross-sectional study was to describe the frequency of IC decline in DLB and to compare it with AD. Design: A single-center cross-sectional study. Setting: This study was carried out in a memory clinic between 2015 and 2023 based on the MEMORA cohort. Participants: Patients with a diagnosis of AD or probable DLB and a comprehensive geriatric assessment. Measurements: IC was assessed according to the WHO model in 4 domains: vitality assessed by the Mini Nutritional Assessment (MNA), locomotion assessed by the Short Physical Performance Battery (SPPB), psychology assessed by the Geriatric Depression Scale 4-items (GDS-4 items), and hearing assessed by the Hearing, Vision, Equilibrium and Cognition (HVEC) scale. Results: A total of 798 patients (154 with probable DLB and 644 with AD) were included, and the mean age was 81.4 years (SD 6.33). Compared with AD patients, DLB patients had significantly more impaired IC in all domains, with greater risks of impaired vitality (odds ratio (OR) 2.43, 95% confidence interval (CI) 1.60–3.72), locomotion (OR 3.50, 95% CI 2.15–5.90), psychology (OR 2.60, 95% CI 1.73–3.92) and hearing (OR 2.30, 95% CI 1.53–3.49), according to the adjusted models. Similarly, when IC domains were considered linear variables, IC across all domains was significantly lower in the DLB group than in the AD group. Conclusion: This study revealed that DLB patients presented a greater decrease in IC than did AD patients across all domains. In memory clinics, DLB patients could be offered systematic and early IC monitoring and personalized interventions. |
| format | Article |
| id | doaj-art-588e968fb5524433b57ef4e78d81d268 |
| institution | DOAJ |
| issn | 1760-4788 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Journal of Nutrition, Health and Aging |
| spelling | doaj-art-588e968fb5524433b57ef4e78d81d2682025-08-20T02:40:43ZengElsevierThe Journal of Nutrition, Health and Aging1760-47882025-06-0129610054110.1016/j.jnha.2025.100541Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional studyMarie Collin0Justine Bonnet-Chateau1Victor Gilles2Sophie Dautricourt3Thomas Gilbert4Zaza Makaroff5Marie-Hélène Coste6Virginie Dauphinot7Antoine Garnier-Crussard8Clinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France; Normandie Univ, UNICAEN, INSERM, U1237, PhIND “Physiopathology and Imaging of Neurological Disorders”, Neuropresage Team, Cyceron, 14000 Caen, FranceResearch on Healthcare Professionals and Performance RESHAPE, Inserm U1290, Université Claude Bernard Lyon 1, 69008 Lyon, France; Geriatric Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, CEDEX, 69495 Pierre-Bénite, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, FranceClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France; Normandie Univ, UNICAEN, INSERM, U1237, PhIND “Physiopathology and Imaging of Neurological Disorders”, Neuropresage Team, Cyceron, 14000 Caen, France; University Claude Bernard Lyon 1, Villeurbanne, France; Corresponding author.Objectives: Intrinsic capacity (IC), the composite of all the physical and mental capacities of an individual, has never been studied in patients with dementia with Lewy bodies (DLB). As IC decline is associated with the risk of frailty, functional decline and disability and is potentially reversible after targeted interventions, a monitoring and specific management of IC decline in patients with DLB could promote healthy aging in this population. The aim of this cross-sectional study was to describe the frequency of IC decline in DLB and to compare it with AD. Design: A single-center cross-sectional study. Setting: This study was carried out in a memory clinic between 2015 and 2023 based on the MEMORA cohort. Participants: Patients with a diagnosis of AD or probable DLB and a comprehensive geriatric assessment. Measurements: IC was assessed according to the WHO model in 4 domains: vitality assessed by the Mini Nutritional Assessment (MNA), locomotion assessed by the Short Physical Performance Battery (SPPB), psychology assessed by the Geriatric Depression Scale 4-items (GDS-4 items), and hearing assessed by the Hearing, Vision, Equilibrium and Cognition (HVEC) scale. Results: A total of 798 patients (154 with probable DLB and 644 with AD) were included, and the mean age was 81.4 years (SD 6.33). Compared with AD patients, DLB patients had significantly more impaired IC in all domains, with greater risks of impaired vitality (odds ratio (OR) 2.43, 95% confidence interval (CI) 1.60–3.72), locomotion (OR 3.50, 95% CI 2.15–5.90), psychology (OR 2.60, 95% CI 1.73–3.92) and hearing (OR 2.30, 95% CI 1.53–3.49), according to the adjusted models. Similarly, when IC domains were considered linear variables, IC across all domains was significantly lower in the DLB group than in the AD group. Conclusion: This study revealed that DLB patients presented a greater decrease in IC than did AD patients across all domains. In memory clinics, DLB patients could be offered systematic and early IC monitoring and personalized interventions.http://www.sciencedirect.com/science/article/pii/S127977072500065XIntrinsic capacityDementia with Lewy bodiesAlzheimer’s disease |
| spellingShingle | Marie Collin Justine Bonnet-Chateau Victor Gilles Sophie Dautricourt Thomas Gilbert Zaza Makaroff Marie-Hélène Coste Virginie Dauphinot Antoine Garnier-Crussard Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study The Journal of Nutrition, Health and Aging Intrinsic capacity Dementia with Lewy bodies Alzheimer’s disease |
| title | Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study |
| title_full | Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study |
| title_fullStr | Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study |
| title_full_unstemmed | Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study |
| title_short | Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer’s disease: A cross-sectional study |
| title_sort | intrinsic capacity in patients with dementia with lewy bodies compared with those with alzheimer s disease a cross sectional study |
| topic | Intrinsic capacity Dementia with Lewy bodies Alzheimer’s disease |
| url | http://www.sciencedirect.com/science/article/pii/S127977072500065X |
| work_keys_str_mv | AT mariecollin intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT justinebonnetchateau intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT victorgilles intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT sophiedautricourt intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT thomasgilbert intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT zazamakaroff intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT mariehelenecoste intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT virginiedauphinot intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy AT antoinegarniercrussard intrinsiccapacityinpatientswithdementiawithlewybodiescomparedwiththosewithalzheimersdiseaseacrosssectionalstudy |